Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

JPMorgan's Dimon: Healthcare initiative may be more about smaller steps than moon shots

It’s natural to expect great things from an initiative attached to three corporate giants, but Jamie Dimon is calling for folks to temper their expectations for the initiative that includes his JPMorgan Chase, Warren Buffett’s Berkshire Hathaway and Jeff Bezos’ Amazon. The trio’s goal is to improve healthcare for their 1.1 million employees, but details surrounding the project have been scant.

Thumbnail

Can self-reported data from patients be trusted? Depends on the outcome

As the saying goes, You can’t always believe what you hear. But when it comes to patients self-reporting health care utilization, just how accurate can people be? A study, published July 30 in the Journal of Medical Internet Research, examined patients’ abilities to recall complications in the 90 days after orthopedic procedures through an automated online patient engagement survey.

Thumbnail

California’s maternal safety measures save lives—so why aren't other states following suit?

California’s maternal death rates been halved as pregnancy-related deaths increase in the U.S. Safety experts and hospitals in California have worked together to implement improved practices. So why haven't other states done the same? A USA Today investigation looks for an answer.

Video recording could limit communication breakdowns between physicians, nurses

Memories aren’t the perfect carbon copies of reality many people believe them to be. One person’s interpretation of an event could be quite different from another participant. Researchers hoped to limit communication breakdowns between nurses and physicians by recording video of interactions, so the participants could review and critique them.

Thumbnail

‘Medicare for all’ would cost $32.6T over 10 years

Considering healthcare will be a central topic in the run up to the 2018 mid-term elections, “Medicare for all” is a concept that is gaining traction among left-leaning politicians. A recent study, though, found that implementation of such a program would cost $32.6 trillion over 10 years.

Thumbnail

FDA approves Abbott’s 14-day continuous glucose monitor

The FDA approved the FreeStyle Libre flash glucose monitoring system, which works for up to 14 days at a time, according to an announcement from device maker Abbott.

Thumbnail

Immelt signs on as consultant for Collective Health

Jeff Immelt, former CEO of General Electric, announced on LinkedIn that he will be advising Collective Health, a start-up that offers software-driven workforce health management systems. The move comes less than a year since he announced his retirement as president and director of GE’s board and less than six months after becoming chairman of Athenahealth.

Thumbnail

ProMedica acquires HCR ManorCare for $4.4B

Toledo, Ohio-based ProMedica announced its acquisition of Quality Care Properties and its principal tenants, HCR ManorCare and Arden Courts. The $4.4 billion transaction was possible thanks to a joint venture with Welltower, an in vestment first focused on healthcare-related real estate.

Displaying 3329 - 3336 of 6655

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup